Shots:

• The US FDA has approved the Freezor and Freezor Xtra cardiac cryoablation focal catheters for the treatment of pediatric atrioventricular nodal reentrant tachycardia (AVNRT)
• The approval was based on the (ICY-AVNRT) and multiple pediatric studies that showed the safety and effectiveness of Freezor and Freezor Xtra cardiac cryoablation catheters & reported the acute procedural success of 95% with no permanent pacemaker due to complete AV block along with high efficacy rates and low AEs
• The freezor cryoablation catheters also includes the freezor MAX cardiac cryoablation catheter which is approved for use in conjunction with the Arctic Front Advance cryoballoon for AF

 Ref: Medtronic | Image: Medtronic